- QLGN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
-
Insider
- Institutional
- Shorts
-
S-1 Filing
Qualigen Therapeutics (QLGN) S-1IPO registration
Filed: 3 Jul 17, 12:00am
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
As independent registered public accountants, we hereby consent to the incorporation by reference in this Registration Statement on Form S-1 and related Prospectus of our report dated February 27, 2017 relating to the financial statements of Ritter Pharmaceuticals, Inc. (which report includes an explanatory paragraph relating to the uncertainty of the Company’s ability to continue as a going concern) for each of the two years ended December 31, 2016, and to the reference to us under the caption “Experts” which is contained in this Prospectus.
/s/ Mayer Hoffman McCann P.C.
Orange County, California
July 3, 2017
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.